2024-11-11T12:13:57-05:00 2023-12-31 274760605 KULLMAN CPA LLC 888 BESTGATE ROAD SUITE 316 ANNAPOLIS MD 21401 990EZ 2023-01-01 300752401 ARM FOUNDATION FOR REGENERATIVE MEDICINE EDUCATION & RESEARCH ARMF 2023453675 1340 SMITH AVENUE SUITE 200 BALTIMORE MD 21209 BRETT KOPELAN CHAIR 2023453675 2024-10-17 true true STEPHEN J KULLMAN CPA P00308157 4102669885 2024-10-17 2023 2024-10-15 13:58:12Z X THEARMFOUNDATION.ORG X X 25000 X 25000 25000 16438 345 39696 56479 -31479 141748 110269 X 154131 121351 154131 121351 12383 11082 141748 110269 X THE ARM FOUNDATION SERVES AS THE EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. BY EXAMINING, QUANTIFYING, CLARIFYING AND INFORMING STAKEHOLDERS OF THE CLINICAL AND SOCIETAL BENEFITS OF THESE THERAPIES, AS WELL AS CONVENING DISCUSSIONS TO RAISE AWARENESS ABOUT THE SECTORS PROGRESS, CHALLENGES AND RESULTS, THE FOUNDATION ACCELERATES PATIENT ACCESS TO SAFE, EFFICACIOUS AND POTENTIALLY CURATIVE THERAPIES. GENE MEDICINE EDUCATION - A STRATEGIC COMMUNICATIONS PROGRAM DESIGNED TO INCREASE AWARENESS AND UNDERSTANDING OF CELL AND GENE THERAPIES AS TRANSFORMATIVE MEDICINES AND IMPORTANT THERAPEUTIC OPTIONS FOR TREATING DISEASE AND EQUIP PEOPLE TO MAKE INFORMED DECISIONS ABOUT CELL AND GENE MEDICINE. THIS INFORMATION IS MADE AVAILABLE TO PATIENTS, CAREGIVERS, PROVIDERS, AND THE GENERAL PUBLIC. 14622 EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. 3432 HEALTH & ECONOMIC IMPACT ANALYSIS - DEVELOP AN IN-DEPTH ANALYSIS OF CELL AND GENE THERAPY AND OTHER REGENERATIVE MEDICINES ON THE NATIONAL AND INTERNATIONAL HEALTHCARE ECONOMIES TO SUPPORT MARKET ACCESS INITIATIVES AND PUBLIC AWARENESS. COMMUNICATING THE SOCIETAL AND ECONOMIC VALUE OF RM THERAPIES THROUGH DATA REPORTING AND STRATEGIC ENGAGEMENT WITH HEALTHCARE PROVIDERS AND THE GENERAL PUBLIC. 1534 CONVENING OF PATIENT GROUP LEADERSHIP WORKSHOP FOR ROUGHLY 25 LEADERS FROM THE PATIENT COMMUNITY TO DISCUSS INITIATIVES TO HELP THEM EDUCATE THEIR CONSTITUENTS ABOUT THE BENEFITS OF CELL AND GENE MEDICINE. 1263 20851 BRETT KOPELAN CHAIR 0.48 0 MARTHA ROOK TREASURER 0.10 0 ADRIAN MCKEMEY SECRETARY 0.10 0 NICOLE BOICE DIRECTOR 0.19 0 SARAH CREVISTON DIRECTOR 0.10 0 JILL ELLIOTT DIRECTOR 0.10 0 ELLEN FEIGAL DIRECTOR 0.10 0 PAT FURLONG DIRECTOR 0.10 0 DON GIBBONS DIRECTOR 0.38 0 CHRISTINA HARTMAN DIRECTOR 0.10 0 MICHAEL MAY DIRECTOR 0.10 0 MARIA MILLAN DIRECTOR 0.10 0 DAVID NAGLER DIRECTOR 0.15 0 EMILE NUWAYSIR DIRECTOR 0.10 0 STEWART PARKER DIRECTOR 0.10 0 DENNIS PURCELL DIRECTOR 0.10 0 BROCK REEVE DIRECTOR 0.10 0 MORRIE RUFFIN DIRECTOR 0.15 0 DAVID SMITH DIRECTOR 0.15 0 ROBERT SMITH DIRECTOR 0.15 0 PHIL VANEK DIRECTOR 0.19 0 JAMES VALENTINE DIRECTOR 0.10 0 MICHAEL WERNER DIRECTOR 0.10 0 CLAUDIA ZYLBERBERG DIRECTOR 0.12 0 false false false false false false false false false ERIN CUMMINGS 1340 SMITH AVENUE SUITE 200 BALTIMORE MD 21209 2023453675 false false false false false false false false false false false NONE NONE true X 670750 959071 493318 3984 25000 2152123 670750 959071 493318 3984 25000 2152123 1323162 828961 2152123 0.38520 0.38930 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED FORM 990-EZ, PART I, LINE 16 EXPENSES ADVERTISING & MARKETING 479 GENERAL ADMINISTRATIVE EX 595 INFORMATION TECHNOLOGY EX 21,215 INSURANCE 8,202 MISCELLANEOUS EXPENSES 2,048 PAYROLL PROCESSING 7,157 TOTAL 39,696 FORM 990-EZ, PART II, LINE 26 ACCOUNTS PAYABLE AND ACCRUED EXPENSES 5,151 3,850 401K PAYABLE 7,232 7,232 FORM 990-EZ, PART III THE ARM FOUNDATION SERVES AS THE EDUCATIONAL AND INFORMATION RESOURCE ON ISSUES FUNDAMENTAL TO MAKING GENE AND CELL THERAPIES, TISSUE-ENGINEERED PRODUCTS AND OTHER REGENERATIVE MEDICINE TREATMENTS AVAILABLE TO PATIENTS. BY EXAMINING, QUANTIFYING, CLARIFYING AND INFORMING STAKEHOLDERS OF THE CLINICAL AND SOCIETAL BENEFITS OF THESE THERAPIES, AS WELL AS CONVENING DISCUSSIONS TO RAISE AWARENESS ABOUT THE SECTORS PROGRESS, CHALLENGES AND RESULTS, THE FOUNDATION ACCELERATES PATIENT ACCESS TO SAFE, EFFICACIOUS AND POTENTIALLY CURATIVE THERAPIES. FORM 990-EZ, PART III, LINE 28 GENE MEDICINE EDUCATION - A STRATEGIC COMMUNICATIONS PROGRAM DESIGNED TO INCREASE AWARENESS AND UNDERSTANDING OF CELL AND GENE THERAPIES AS TRANSFORMATIVE MEDICINES AND IMPORTANT THERAPEUTIC OPTIONS FOR TREATING DISEASE AND EQUIP PEOPLE TO MAKE INFORMED DECISIONS ABOUT CELL AND GENE MEDICINE. THIS INFORMATION IS MADE AVAILABLE TO PATIENTS, CAREGIVERS, PROVIDERS, AND THE GENERAL PUBLIC. FORM 990-EZ, PART III, LINE 30 HEALTH & ECONOMIC IMPACT ANALYSIS - DEVELOP AN IN-DEPTH ANALYSIS OF CELL AND GENE THERAPY AND OTHER REGENERATIVE MEDICINES ON THE NATIONAL AND INTERNATIONAL HEALTHCARE ECONOMIES TO SUPPORT MARKET ACCESS INITIATIVES AND PUBLIC AWARENESS. COMMUNICATING THE SOCIETAL AND ECONOMIC VALUE OF RM THERAPIES THROUGH DATA REPORTING AND STRATEGIC ENGAGEMENT WITH HEALTHCARE PROVIDERS AND THE GENERAL PUBLIC. FORM 990-EZ, PART III, LINE 31 CONVENING OF PATIENT GROUP LEADERSHIP WORKSHOP FOR ROUGHLY 25 LEADERS FROM THE PATIENT COMMUNITY TO DISCUSS INITIATIVES TO HELP THEM EDUCATE THEIR CONSTITUENTS ABOUT THE BENEFITS OF CELL AND GENE MEDICINE.